{"result": {"id": "3a0cfad5-7951-4a21-a27f-5863b4ca8470", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"PCSK9 Inhibitors and Related Entities\",\n    \"summary\": \"The community centers around PCSK9 inhibitors, a class of drugs including evolocumab, alirocumab, toleisumab, and inclisiran, used to lower LDL-C levels. These drugs are related through their mechanism of action and their combined use with cholesterol absorption inhibitors, as well as their effects on arteriosclerotic plaques.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant role of PCSK9 inhibitors in managing cholesterol levels and their potential to stabilize arteriosclerotic plaques, impacting cardiovascular health.\",\n    \"findings\": [\n        {\n            \"summary\": \"PCSK9 inhibitors as a pivotal class of drugs\",\n            \"explanation\": \"PCSK9 inhibitors, including evolocumab, alirocumab, toleisumab, and inclisiran, play a crucial role in lowering LDL-C levels by increasing LDL receptor numbers on cell membranes. Their ability to also stabilize atherosclerotic plaques, provide anticoagulation, and anti-inflammation effects underscores their importance in cardiovascular health management. [Data: Entities (4437, 4438, 4439, 4440, 4441,+more)]\"\n        },\n        {\n            \"summary\": \"Combination therapy with cholesterol absorption inhibitors\",\n            \"explanation\": \"PCSK9 inhibitors can be effectively combined with cholesterol absorption inhibitors to enhance LDL-C level reduction. This combination therapy represents a significant advancement in the treatment of hypercholesterolemia and mixed dyslipidemia, offering patients more comprehensive treatment options. [Data: Relationships (4293)]\"\n        },\n        {\n            \"summary\": \"Impact on arteriosclerotic plaques\",\n            \"explanation\": \"One of the notable effects of PCSK9 inhibitors is their ability to stabilize arteriosclerotic plaques. This effect is crucial in preventing plaque rupture, a common cause of cardiovascular events such as heart attacks and strokes, highlighting the inhibitors' broader impact on cardiovascular health beyond just lowering cholesterol levels. [Data: Relationships (4294)]\"\n        },\n        {\n            \"summary\": \"Inclisiran's recent approval in China\",\n            \"explanation\": \"Inclisiran, a small interfering RNA (siRNA) targeting PCSK9, was approved in China in August 2023 for treating primary hypercholesterolemia and mixed dyslipidemia in adults. This approval marks a significant milestone in the availability of innovative treatments for cholesterol management in the region. [Data: Entities (4441)]\"\n        },\n        {\n            \"summary\": \"Diverse mechanisms of action among PCSK9 inhibitors\",\n            \"explanation\": \"The PCSK9 inhibitors, including monoclonal antibodies like evolocumab, alirocumab, and toleisumab, as well as the siRNA inclisiran, exhibit diverse mechanisms of action. This diversity allows for tailored treatment approaches based on patient needs and responses, enhancing the flexibility and effectiveness of cholesterol management strategies. [Data: Entities (4438, 4439, 4440, 4441)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560414, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 660, "prompt_tokens": 2561, "total_tokens": 3221, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1472}, "prompt_cache_hit_tokens": 1472, "prompt_cache_miss_tokens": 1089}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n4437,PCSK9 INHIBITORS,\"PCSK9 inhibitors are a class of drugs that include evolocumab, alirocumab, and toleisumab, used to lower LDL-C levels by increasing LDL receptor numbers on cell membranes and promoting LDL-C clearance. They also have effects like stabilizing atherosclerotic plaques, anticoagulation, and anti-inflammation.\"\"\",10\n4438,EVOLOCUMAB,\"Evolocumab is a PCSK9 monoclonal antibody used to lower LDL-C levels, either as monotherapy or in combination with statins or cholesterol absorption inhibitors.\"\"\",1\n4439,ALIROCUMAB,\"Alirocumab is a PCSK9 monoclonal antibody used to lower LDL-C levels, either as monotherapy or in combination with statins or cholesterol absorption inhibitors.\"\"\",1\n4440,TOLEISUMAB,\"Toleisumab is a PCSK9 monoclonal antibody used to lower LDL-C levels, either as monotherapy or in combination with statins or cholesterol absorption inhibitors.\"\"\",1\n4441,INCLISIRAN,\"Inclisiran is a small interfering RNA (siRNA) targeting PCSK9, approved in China in August 2023 for treating primary hypercholesterolemia and mixed dyslipidemia in adults.\"\"\",1\n4449,CHOLESTEROL ABSORPTION INHIBITORS,\"Another class of drugs mentioned as being potentially combined with PCSK9 inhibitors\"\"\",1\n4450,ARTERIOSCLEROTIC PLAQUES,\"Plaques mentioned as being stabilized by PCSK9 inhibitors\"\"\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n4286,PCSK9 INHIBITORS,EVOLOCUMAB,Evolocumab is a type of PCSK9 inhibitor,11\n4287,PCSK9 INHIBITORS,ALIROCUMAB,Alirocumab is a type of PCSK9 inhibitor,11\n4288,PCSK9 INHIBITORS,TOLEISUMAB,Toleisumab is a type of PCSK9 inhibitor,11\n4289,PCSK9 INHIBITORS,INCLISIRAN,Inclisiran is a type of PCSK9 inhibitor,11\n4293,PCSK9 INHIBITORS,CHOLESTEROL ABSORPTION INHIBITORS,PCSK9 inhibitors can be combined with cholesterol absorption inhibitors,11\n4294,PCSK9 INHIBITORS,ARTERIOSCLEROTIC PLAQUES,PCSK9 inhibitors help stabilize arteriosclerotic plaques,11\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_5eb6ca9f7b1d400851b0f89f0e081d11b8bbca6f6d8ea2467f9784b4fa5db57f_v2"}